PART1 and laryngeal carcinoma: identified 5 lncRNAs (TSPEAR-AS, ​​CASK-AS1, MIR137HG, Part1, LSAMP-AS1) as potential prognostic markers and therapeutic targets for laryngeal cancer, which is consistent with our results (43).